The subsidiary of Jincheng Pharmaceutical has successfully obtained the European CEP (Certificate of Suitability) for Oseltamivir Phosphate Active Pharmaceutical Ingredient (API). This milestone signifies that its products adhere to the stringent standards set by the European Pharmacopoeia, paving the way for their sale in Europe and other international markets that recognize CEP certifications.
